Open AccessHepatitis B Virus Reactivation Under Treatment with Ibrutinib, A Known and Still Dangerous Entity: A Clinical Case Description
Author(s) -
Justine Adnet,
Emilie Réboursière,
Bertille Comoz,
Louise Lebedel,
Charlotte Orhan,
Astrid Vabret,
Isabelle OllivierHourmand,
Julia Din
Publication year - 2021
Publication title -
frontiers in medical case reports
Language(s) - English
Resource type - Journals
ISSN - 2582-8142
DOI - 10.47746/fmcr.2021.2606
Subject(s) - ibrutinib , hepatitis b virus , medicine , hepatitis b , virology , context (archaeology) , hbsag , immunology , serology , virus , antibody , biology , leukemia , paleontology , chronic lymphocytic leukemia